Global Incontinence and Ostomy Care Industry, 2026 - Major Players are Coloplast, Convatec, Domtar, Essity Aktiebolag, Hollister, Kimberly-Clark, Medtronic, Ontex, Paul Hartmann, and Unicharm

DUBLIN, Aug. 14, 2020 /PRNewswire/ -- The "Incontinence and Ostomy Care Global Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

An increase in an aging population, increased utilization of the various incontinence and ostomy care products for the management or treatment of different types of incontinence and ostomy surgeries among patients, a growing inclination towards technologically advanced incontinence and ostomy care products with better therapeutic outcomes and also increasing awareness about the disease and the availability of the wide varieties of products to manage or treat the disease conditions are fuellng growth in the incontinence and ostomy care global market.

The global incontinence and ostomy care global market is expected to reach $24,577.9 million by 2026 growing at a mid single digit from 2019 to 2026, due to an increase in the population prone to aging related medical conditions, a growing prevalence of medical conditions such as women's health related conditions (e.g. childbirth, menopause), inflammatory bowel diseases (crohn's disease and ulcerative colitis), neurological diseases (multiple sclerosis, Parkinson's disease), oncology (colorectal and prostate cancer) and others diseases.

In addition, increasing awareness & acceptance of the condition of incontinence & ostomy, growing economies and increasing demand for better healthcare facilities in emerging markets is driving the market forward.

The incontinence and ostomy market is segmented by product, utility, application, end-user and geography.

Based on product type, the incontinence and ostomy care global market is segmented into incontinence and ostomy care. The incontinence care segment is the largest and fastest growing product segment and is expected to grow at a mid single digit CAGR from 2019 to 2026.

• Based on disease type, the incontinence care market is classified into urinary incontinence and fecal incontinence. Urinary incontinence accounted for the largest and fastest growing segment and is expected to grow at a mid single digit CAGR from 2019 to 2026.
• Based on product type, the incontinence care market is segment into disposables and implantable device. Among these segments, the disposables segment accounted for the largest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Implant devices are the fastest growing segment at a high single digit CAGR from 2019 to 2026.
• In the disposable global market by type, the adult diapers segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit from 2019 to 2026. Incontinence Catheter is the fastest growing segment at a mid single digit CAGR from 2019 to 2026. Among the overall adult diaper market by type, the underwear & briefs segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Pads & Guards is the fastest growing segment at a mid single digit CAGR from 2019 to 2026.
• In the implant devices by product type, the Sacral Nerve Stimulation (SNS) segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026.

Based on utility, the incontinence and ostomy care global market is segmented into security & leakage control, protection & cleansing, odor control and irrigation products. The Security & Leakage control segment is the largest and fastest growing segment and expected to grow at mid single digit CAGR from 2019 to 2026, due to increasing use of security and leakage control devices for incontinence and stoma management and increasing technological advancement in these devices to increase efficiency.

Based on application, the incontinence and ostomy global market is segmented into women's health related, neurological conditions, oncology, urinogenital diseases, GI Tract diseases and others. The women's health related segment accounted for the largest revenue in 2019 and is expected to grow at mid single digit CAGR from 2019 to 2026. The oncology segment is the fastest growing segment and is projected to grow at mid single digit CAGR from 2019 to 2026 due to increases in the prevalence of prostate, colorectal and bladder cancers.

Based on end-users, the market has been segmented into hospitals, home care, and others that consist of clinics and research institutes. Homecare accounted for the largest revenue in 2019 and it expected to grow at mid single digit CAGR from 2019 to 2026 due to the availability of better and technologically advanced personalized incontinence and stoma management products. Hospitals is the fastest growing segment and is projected to grow at a mid single digit CAGR from 2019 to 2026 due to increasing availability of various advanced minimally invasive treatments.

Based on region, the market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & Africa). Europe accounted for the largest revenue in 2019 and is expected to growing at a low single digit CAGR from 2019 to 2026 due to the increasing prevalence of targeted disease in the region, a growing geriatric population, increasing penetration and adoption of advanced products and increasing R&D spending for developing innovative and technologically advanced products.

Asia-Pacific is the fastest growing region and is expected to grow at a high single digit CAGR from 2019 to 2026 due to an increasing geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes in developing countries, growing demand for better healthcare facilities from the population in the region and growing economies of the region, availability of various kinds of incontinence and ostomy management products and increasing medical tourism prospects in the region.

Some of the major players in the incontinence and ostomy care market include Essity AB (Sweden), Coloplast A/S (Denmark), Kimberly-Clark Corporation (U.S.), Unicharm Corporation (Japan), ConvaTec Group plc (U.K.), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Ontex (Belgium), Paul Hartmann AG (Germany), Procter & Gamble Company (U.S.), Hollister Incorporated (U.S.), Salts Healthcare (U.K.), First Quality Enterprises, Inc. (U.S.), Abena A/S (Denmark), Becton, Dickinson and Company (U.S.), Medline Industries, Inc., (U.S.), Domtar Corporation (U.S.) and others.

Key Topics Covered

1 Executive Summary

2 Introduction

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increase in Aging Population
3.3.1.2 Development of Innovative and Personalized Products
3.3.1.3 Increase in Awareness and Acceptance
3.3.1.4 Increase in Prevalence of Chronic Diseases
3.3.2 Restraints and Threats
3.3.2.1 Environment and Disposal Concerns
3.3.2.2 Low Cost Manufactures
3.3.2.3 Alternative Medical Treatment
3.3.2.4 Limited Reimbursement
3.4 Regulatory Affairs
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.1.3 ISO 10993 Biological Evaluation of Medical Devices
3.4.1.4 ISO 14971 Risk Management of Medical Devices
3.4.1.5 IEC 60601-1 Medical Electrical Equipment Standard
3.4.1.6 IEC 60601-1-11 Home Care Safety
3.4.2 U.S.
3.4.3 Europe
3.4.4 Japan
3.4.5 China
3.4.6 India
3.5 Patent Analysis
3.6 Technological Advancements
3.6.1 Smart Diapers
3.6.2 Smart Bags
3.6.3 Wearble Diaper Free Devices (Dfree)
3.6.4 Wearble Pelvic Floor Muscle Stimulation Devices
3.6.5 Advancements in Biomaterials
3.6.6 Increased Absorbence and Antibacterial Solutions
3.6.7 Moldable Technology
3.6.8 Next Generation Ostomy Implants
3.7 Porter's Five Force Analysis
3.8 Supply Chain Analysis
3.9 Reimbursement Scenario
3.10 Pipeline Analysis
3.11 Incontinence and Ostomy Care Market Penetration, Prevalence and Opportunity
3.11.1 Adult Diapers Market Penetration, Prevalence and Opportunity
3.11.2 Ostomy Market Penetration, Prevalence and Opportunity
3.12 Market Share Analysis by Major Players
3.12.1 Incontinence and Ostomy Care Global Market Share Analysis
3.12.2 Incontinence Care Global Market Share Analysis
3.12.3 Ostomy Care Global Market Share Analysis
3.12.4 Adult Diapers Global Market Share Analysis
3.12.4.1 North America Adult Diapers Market Share Analysis
3.12.4.2 Europe Adult Diapers Market Share Analysis
3.12.4.3 Asia-Pacific Adult Diapers Market Share Analysis
3.12.4.4 Rest of the World Adult Diapers Market Share Analysis
3.13 Incontinence and Ostomy Care Company Comparison Table by Product Type, Product Name and Application

4 Incontinence and Ostomy Care Global Market, By Product
4.1 Introduction
4.2 Incontinence Care
4.3 Ostomy Care

5 Incontinence and Ostomy Care Global Market, By Utility
5.1 Introduction
5.2 Security and Leakage Control
5.3 Odor Control
5.4 Protection and Cleansing
5.5 Irrigation Products

6 Incontinence and Ostomy Care Global Market, By Application
6.1 Introduction
6.2 Women Health Related
6.3 GI Tract Diseases
6.4 Oncology
6.5 Neurological Conditions
6.6 Urinogenital Diseases
6.7 Other Diseases

7 Incontinence and Ostomy Care Global Market, By End-User
7.1 Introduction
7.2 Hospitals
7.3 Homecare
7.4 Other End-User

8 Regional Analysis
8.1 Introduction
8.2 North America
8.3 Europe
8.4 APAC
8.5 RoW

9 Competitive Landscape
9.1 Introduction
9.2 Acquisitions and Partnerships
9.3 Product Launches
9.4 Product Approvals
9.5 Others

10 Major Companies Profiled
10.1 Coloplast A/S
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Key Developments
10.1.5 Business Strategy
10.1.6 Swot Analysis
10.2 Convatec Group PLC
10.3 Domtar Corporation
10.4 Essity Aktiebolag
10.5 Hollister Incorporated
10.6 Kimberly-Clark Corporation
10.7 Medtronic PLC
10.8 Ontex
10.9 Paul Hartmann AG
10.10 Unicharm Corporation

Companies Mentioned

• 3M
• 11 Health and Technologies Limited
• A.M.I. GmbH
• Abena AS
• Adapta Medical, Inc.
• Affluent Medical SA
• ALBAAD Massuot Yitzhak LTD
• ALCARE Co., LTD
• AmeriDerm Laboratories, LTD
• Axonics Modulation Technologies, Inc.
• B. Braun Melsungen Ag
• Becton, Dickinson And Company
• Betatech Medical
• Birchwood Laboratories LLC
• Bluewind Medical
• Boston Scientific
• Bray Group LTD
• Caldera Medical Inc.
• Care Corporation
• Changzhou Medical Appliances General Factory co., LTD
• Chiaus (Fujian) Industrial Development Co., LTD
• CL Medical
• Coloplas A/S
• ConvaTec Group Plc
• Cousin Biotech
• Cymed Ostomy Co
• Cardinal Health, Inc.
• Cymed Ostomy Co
• Daio Paper Corporation
• Dipro Medical Devices S.R.L.
• Domtar Corporation
• Drylock Technologies
• Elidah, Inc.
• Essity AB
• Eurofil Srl
• Femeda LTD
• First Quality Enterprises, Inc.
• Flat-D Innovations Inc.
• Flexicare Medical LTD
• Flexiprobe LTD.
• GT Urological LLC
• Helioscopie
• Hengan International
• Hollister Incorporated
• Hunter Urology
• InControl Medical, LLC
• Implantica Trading Ag
• Johnson & Johnson (Ethicon)
• Kamal healthcare products private limited
• Kimberly-Clark Corporation
• LABORIE Medical Technologies
• MacGregor Healthcare LTD
• Marlen Manufacturing & Development Co.
• MedGyn Products Inc.
• Mediplus LTD.
• Medtronic, Plc
• Mega disposables S.A.
• Nobel Hygiene Limited
• Nu-Hope Labs
• OakMed LTD
• Ontex
• Ostofresh
• Ostomy Essentials
• Oxmed International
• Ostoform LTD.
• Ostomycure AS
• Paul Hartmann AG
• Perfect Choice Medical Technologies
• Principle Business Enterprises
• Procter & Gamble Company
• Resilia Medical Solutions
• SAEHAN Co., LTD.
• Safe N Simple LLC
• Salts Healthcare
• Securi-T
• Simavita Limited
• Sterimed Medical Devices Pvt. LTD
• TG Eakin Limited
• THT Bio-science group
• Tilla Care LTD.
• Torbot Group Inc.
• TG Eakin Limited
• THT Bio-science group
• Na'Scent
• Trio Healthcare LTD.
• Triple W
• TZMO SA
• Unicharm Corporation
• Unique Wellness
• Uriclak
• Urocare Products Inc
• Welland Medical LTD
• Wiesner Healthcare Innovation LLC
• Zephyr Surgical Implants

For more information about this report visit https://www.researchandmarkets.com/r/wcv6vi

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com